Catheter-based renal denervation is a promising contemporary evolution of a historical treatment for hypertension and aims to achieve a reduction in renal sympathetic activation. This has been ...

Renal denervation; RSDforAF: Renal sympathetic denervation for AF. 1 Pole de Recherche Cardiovasculaire, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain ...

Medtronic says CMS is opening a national coverage analysis on renal denervation (RDN) procedures for patients with ...

The Paradise uRDN system is currently commercially available for patients in the US having received FDA approval in November 2023. It is indicated to reduce blood pressure as an adjunctive treatment ...

On Monday, the Centers for Medicare & Medicaid Services (CMS) initiated a national coverage analysis of renal denervation for the treatment of uncontrolled hypertension.

The Centers for Medicare & Medicaid Services will review a potential national Medicare coverage policy for renal denervation ...

Medtronic and Recor Medical, Inc. separately announced that the Centers for Medicare & Medicaid Services (CMS) is opening a ...

According to WK, Paradise Ultrasound Renal Denervation is an FDA-approved ... artery into the renal artery to reduce the activity of sympathetic renal nerves. Dr. Master said clinical trials ...

U.S. Medicare coverage of renal denervation (RDN) for uncontrolled hypertension may soon be a fact of life if the manufacturers of these systems have their way. CMS opened a national coverage analysis ...